Loading…
Loading…
Structured register of government actions in the geoeconomic space — export controls, tariffs, sanctions, FDI screening, subsidies, industrial-policy laws — cross-referenced into the country, minerals, and ETF surface. Charter: docs/IPTM_CHARTER.md.
Severity 1-5 is the qualitative impact rating (1=minor, 5=structural). The bilateral-trade-grounded quant scorer is the next IPTM milestone. RBI (Register Breadth Index) is a complementary structural-breadth indicator from scripts/py/iptm/breadth.py; divergence between RBI and severity is itself informative (high-sev / low-RBI = strategic chokepoint; low-sev / high-RBI = broad but shallow). Every action has at least one primary source URL. Verify-or-don't-file. See also themes, timeline, graph, sankey, map, country exposure, sector exposure, material exposure (+ graph), weekly briefs, portfolio scan, escalation monitor, trans-shipment hubs. Internal triage tools (RSS-poller candidate feed, source-feed health) live under /admin/candidates + /admin/sources. Subscribe via Atom feed (accepts ?country=CN, ?material=lithium, ?issuer=BIS, ?type=export_control, ?etf=SOXX, ?company=NVDA, ?minSeverity=4, ?year=2026, ?q=…) or pull /api/iptm/actions.
Innovate UK (part of UKRI) opened the Growth Catalyst - Investor Partnerships Round 2 competition on 10 December 2025, allocating a minimum of £100 million in grant funding to UK-registered SMEs at seed-to-Series-A stage. Grants (60-70% of project costs for feasibility and industrial-research projects; 35-45% for experimental development) must be matched by private investment from an Innovate UK-approved investor partner, ranging from an equal match to double the grant amount depending on project category. Applicants must align with one of the priority sectors named in the UK's Modern Industrial Strategy ("Invest 2035"): advanced manufacturing, clean energy, digital and technologies, defence, creative industries, life sciences, or the Battery Innovation Programme. The competition closes 3 February 2026.
On 19 October 2025 the UK government announced an additional GBP 20 million each for Greater Manchester, the West Midlands, and Glasgow City Region under the GBP 500 million Local Innovation Partnerships Fund (LIPF), topping up their original GBP 30 million earmarked allocation (June 2025 Spending Review) to GBP 50 million per region. The three areas were the first cohort to run UKRI's predecessor Innovation Accelerators programme. Funds are channelled through UKRI to local "triple helix" partnerships (civic institutions, business, universities) for innovation-cluster projects in life sciences, advanced manufacturing, AI adoption, and clean-energy/fuel technologies. The announcement preceded the 21 October 2025 Regional Investment Summit in Birmingham.
On 17 June 2025, at the Paris Air Show, the UK Department for Business and Trade announced over £250 million in joint government-and-industry funding for green aerospace research and technology projects, drawn from a £975 million allocation to the Aerospace Technology Institute (ATI) Programme for 2025-2030. The tranche covers 11 major projects plus 18 smaller initiatives, led by Airbus, Rolls-Royce and Intelligent Energy, targeting hydrogen propulsion, additive manufacturing and engine-efficiency technologies aimed at net-zero aviation.
In the Spending Review 2025 (delivered 11 June 2025), HM Treasury committed "over £2.5 billion" for nuclear fusion, explicitly including support for the UK's STEP (Spherical Tokamak for Energy Production) programme to design and build a prototype fusion power plant on the site of the former West Burton A coal power station in Nottinghamshire. The commitment covers the multi-year Spending Review period and is administered through the UK Atomic Energy Authority. STEP construction is expected to begin in the 2030s, with first operations targeted for 2040, and the government cites over 10,000 jobs supported by the programme.
The UK Department for Science, Innovation and Technology signed a grant agreement with BioNTech UK Ltd. providing up to GBP 129 million in government support over 10 years, underpinning BioNTech's planned GBP 1 billion (USD 1.3 billion) investment in UK research and development over the same period. The funding backs two new R&D hubs: a life-sciences research centre in Cambridge (genomics, oncology, structural biology, regenerative medicine) and an AI hub co-located with BioNTech's planned UK headquarters in London, run by its InstaDeep subsidiary. The government frames the deal as one of the largest single-company investments in UK life-sciences history and part of the Oxford-Cambridge Growth Corridor and Plan for Change industrial strategy.